LY6K and breast cancer: High Ly6K mRNA expression in breast cancer was significantly correlated with decreased three-year overall survival (dead, n=31 vs alive, n=295) and one-year overall survival (dead, n=3 vs alive n=156) in Kao [52] and Pawitan [115] studies.